InvestorsHub Logo
Followers 37
Posts 6425
Boards Moderated 3
Alias Born 05/06/2014

Re: longboarder7892 post# 144696

Thursday, 12/01/2022 12:48:07 PM

Thursday, December 01, 2022 12:48:07 PM

Post# of 144813

"Austrianova’s clinically tested Cell-in-a-Box cell encapsulation technology is the subject of a Drug Master File (DMF) that has been filed with FDA as well as included by PharmaCyte Biotech Inc., in their IND for a Phase 2B clinical trial for pancreatic cancer. Phase 2B studies are generally ‘mini-phase 3’ studies that provide data on efficacy as well as on safety. "



This is meaningless. PMCB'S IND was rejected and no new IND was ever filed.. Now the new management has put a hold on any further work towards filing any new IND.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PMCB News